Newsroom
Sorted by: Latest
-
Biocytogen verkündet klinischen Meilenstein: Erster Patient in Phase-1-Studie von IDEAYAs erstklassigem B7H3/PTK7-bispezifischen TOP1-ADC IDE034 behandelt
BEIJING, China--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), ein globales Biotechnologieunternehmen, das die Forschung und Entwicklung neuartiger antikörperbasierter Medikamente mit innovativen Technologien vorantreibt, gab heute bekannt, dass sein Partner IDEAYA Biosciences, Inc. („IDEAYA“; Nasdaq: IDYA) den ersten Patienten in der klinischen Phase-1-Dosis-Eskalations-/Expansionsstudie von IDE034 behandelt hat. IDE034 ist ein in der Er...
-
AARD Investors Have Opportunity to Join Aardvark Therapeutics, Inc. Fraud Investigation With the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--AARD Investors Have Opportunity to Join Aardvark Therapeutics, Inc. Fraud Investigation with the Schall Law Firm...
-
KnowBe4 lanza AIDA Orchestration como el primer agente totalmente autónomo para la gestión del riesgo humano
MEXICO CITY--(BUSINESS WIRE)--KnowBe4, la mundialmente reconocida plataforma de renombre mundial que aborda de manera integral la gestión de riesgos humanos y de agentes de IA, anunció hoy el lanzamiento de AIDA Orchestration, el octavo agente impulsado por IA en la suite de agentes de KnowBe4 para la gestión del riesgo humano conocida como AIDA (Artificial Intelligence Defense Agents). El agente AIDA Orchestration es un sistema autónomo basado en IA para la gestión del riesgo humano. Crea, pro...
-
KnowBe4 lança AIDA Orchestration como o primeiro agente totalmente autônomo para Gestão de Risco Humano
SÃO PAULO--(BUSINESS WIRE)--A KnowBe4, plataforma mundialmente reconhecida que aborda de forma abrangente a gestão de riscos humanos e de agentes de IA, anunciou hoje o lançamento do AIDA Orchestration. Este é o oitavo agente impulsionado por inteligência artificial na suíte de agentes da KnowBe4 para gestão de risco humano, conhecida como Artificial Intelligence Defense Agents (AIDA). O agente AIDA Orchestration é um sistema autônomo baseado em IA para a gestão de risco humano. A ferramenta cr...
-
KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC)
RAHWAY, N.J.--(BUSINESS WIRE)--KEY + WEL as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death Compared to KEYTRUDA Mono in Certain Patients With Earlier-Stage RCC...
-
WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)
RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)--WELIREG Plus LENVIMA Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated RCC Patients...
-
Berkshire Hathaway Inc. News Release
OMAHA, Neb.--(BUSINESS WIRE)--(BRK.A; BRK.B) – Berkshire’s operating results for the fourth quarter and full year of 2025 and 2024 are summarized in the following paragraphs. However, we urge investors and reporters to read our 2025 Annual Report, which has been posted at www.berkshirehathaway.com. The limited information that follows in this press release is not adequate for making an informed investment judgment. Earnings of Berkshire Hathaway Inc. and its consolidated subsidiaries for the fo...
-
The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders
CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers, and retailers of cannabis products in the United States, today announced that the ad hoc group of noteholders of the Company’s 9.25% Senior Secured Notes due December 31, 2028 and the 9.00% Senior Secured Convertible Notes due December 31, 2028 (collectively, the “Notes”), which are parties to t...
-
KIRIN HYOKETSU Expands into U.S. RTD Market with Local Production
TOKYO--(BUSINESS WIRE)--New Belgium Brewing, the Kirin Group company leading its U.S. alcoholic beverage business, will launch two original flavors - KIRIN HYOKETSU STRAWBERRY and KIRIN HYOKETSU PINEAPPLE – under the KIRIN HYOKETSU (HYOKETSU) brand, manufactured and sold by Kirin Brewery Company, Limited (Kirin Brewery). The ready to drink cocktail will be available in Hawaii, Tampa, FL, and The Japan Pavilion at EPCOT theme park, operated by Mitsukoshi (U.S.A.), on March 2. Created with Americ...
-
CWH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Camping World Holdings, Inc.
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Camping World Holdings, Inc. (“Camping World” or the “Company”) (NYSE:CWH) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On October 28, 2025, Camping World issued a press release announcing its third-quarter 2025 financial...